The Cool Chain Association (CCA) last week launched a COVID-19 Distribution Change Management Matrix aimed at supporting airports to prepare their logistics for COVID-19 vaccines in a methodical way.

The matrix looks at adherence to temperature requirements, packaging, forecast and quantity, and timeframe across different stages in a vaccine’s journey through an airport.

CCA members will fill it out and then bring together the information to help the supply chain focus on potential pinch points, training needs, safety and security, as well as supplier and risk management, and quality.

The matrix also incorporates sections on facilities, warehouse, and ramp operations.

Also read: Cold chain group, IATA agree on polishing pharma handling and transport standards

“CCA members can share vital information, which, once consolidated, will provide a useful resource as the industry prepares in the best way we can for the distribution of the vaccines,” said Nicola Caristo, secretary general of the CCA and airline partner manager at SkyCell.

“We are not aiming to suddenly find an end-to-end solution, but focussing on airports, where we know there are potential bottlenecks and where we can use the vast knowledge in our network to help establish workable guidelines.”

The scheme was unveiled during CCA’s recent COVID-19 Taskforce Workshop, where the focus was also placed on the need for both shippers and legislators to play their part.

“It will be essential to have the buy-in from Customs and other legislators,” said CCA Board member Fabrizio Iacobacci, head of pharma business development at Bcube Air Cargo.

”But we should also look at encouraging shippers to be involved and start investing in signing up for Known Shipper status wherever possible to help speed up the process.”